Unicycive Therapeutics In... (UNCY)
NASDAQ: UNCY
· Real-Time Price · USD
4.71
0.08 (1.73%)
At close: Aug 15, 2025, 3:59 PM
4.72
0.32%
After-hours: Aug 15, 2025, 07:57 PM EDT
Unicycive Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -21.12M | -42.65M | -28.93M | -29.16M | -36.93M | -30.54M | -28.07M | -29.3M | -29.1M | -18.06M | -15.48M | -15.13M | -12.59M | -10.02M | -8.14M | -3.65M | -2.88M |
Depreciation & Amortization | 279K | 428K | 376K | 332K | 523K | 284K | 244K | 205K | 167K | 161K | 120K | 80K | 40K | 1K | n/a | n/a | n/a |
Stock-Based Compensation | 2.39M | 2.35M | 2.32M | 2.64M | 2.15M | 1.77M | 1.41M | 751K | 901K | 1.05M | 1.08M | 1.05M | 1.05M | 966K | 806K | 637K | 403K |
Other Working Capital | -2.66M | -1.59M | -1.63M | 688K | -582K | -1.46M | -2.53M | -1.61M | -123K | -89K | 716K | -740K | -1.02M | -1.35M | -1.76M | -124K | -172K |
Other Non-Cash Items | -80K | 11.73M | 1.06M | 1.42M | 12.02M | 10.59M | 8.72M | 8.47M | 9.15M | -913K | -1.02M | 3.39M | 3.42M | 3.39M | 3.72M | 1.16M | 873K |
Deferred Income Tax | n/a | n/a | -287K | -287K | -287K | -287K | n/a | 1.65M | 1.24M | 1.24M | 1.24M | -406K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.32M | -427K | -1.01M | 3.42M | 1.71M | -93K | -2.23M | -841K | 1.02M | 1.18M | 3.4M | 435K | 328K | -105K | -1.28M | -284K | -451K |
Operating Cash Flow | -31.02M | -28.57M | -26.47M | -21.64M | -20.82M | -18.28M | -19.93M | -19.07M | -16.61M | -15.65M | -10.97M | -10.88M | -8.05M | -5.77M | -4.9M | -2.13M | -2.06M |
Capital Expenditures | -82K | -72K | -50K | -26K | -18K | -12K | -14K | -14K | -2K | -4K | -31K | -31K | -31K | -29K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -82K | -72K | -50K | -26K | -18K | -12K | -14K | -14K | -2K | -4K | -31K | -31K | -31K | -29K | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 174K | 875K | 1.38M | 2.24M | 2.11M |
Common Stock Repurchased | n/a | n/a | -11.66B | 11.75B | -1.33B | -1.33B | 10.32B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -1.3M | -1.51M | -2.17M | -2.17M | -1.07M | -1.06M | -192K | -192K | -192K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.52M | -527K | -574K | -468K | -752K | -2.65M | -2.93M | -2.88M | -2.88M | -482K | 18.72M | 40.2M | 40.1M | 40.22M | 21.48M | -101K | 94K |
Financial Cash Flow | 1.94M | 45.09M | 44.52M | 44.62M | 45.44M | 27.54M | 27.27M | 27.33M | 27.33M | -471K | n/a | 21.48M | 21.55M | 22.38M | 22.85M | 2.13M | 2.2M |
Net Cash Flow | -29.16M | 16.44M | 18M | 22.96M | 24.6M | 9.25M | 7.33M | 8.24M | 10.71M | -16.12M | -11M | 10.57M | 13.47M | 16.58M | 17.95M | n/a | 145K |
Free Cash Flow | -31.1M | -28.65M | -26.52M | -21.66M | -20.84M | -18.3M | -19.94M | -19.08M | -16.62M | -15.65M | -11M | -10.91M | -8.08M | -5.8M | -4.9M | -2.13M | -2.06M |